FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917999849> ?p ?o ?g. }

• W2917999849 endingPage "1218" @default.
• W2917999849 startingPage "1209" @default.
• W2917999849 abstract "Abstract Introduction To reduce health care costs and improve care, payers and physician groups are piloting value-based and episodic or bundled-care payment models in oncology. Disease progression and associated costs may affect these models, particularly if such programs do not account for disease severity and progression risk across patient populations. This study estimated the incremental cost of disease progression in patients diagnosed with metastatic breast cancer (mBC), colorectal cancer (mCRC) and lung cancer (mLC) and compared costs among patients with and without progression. Methods This was a retrospective study using U.S. administrative claims data from commercial and Medicare Advantage health care enrollees with evidence of mBC, mCRC, and mLC and systemic antineoplastic agent use from July 1, 2006, to August 31, 2014. Outcome measures included disease progression, 12-month health care costs, and 3-year cumulative predictive health care costs. Results Of 5,709 patients with mBC, 3,707 patients with mCRC, and 5,201 patients with mLC, 56.8% of patients with mBC, 58.1% of those with mCRC, and 80.3% of those with mLC patients had evidence of disease progression over 12 months. Among patients with mBC and mCRC, adjusted and unadjusted health care costs were significantly higher among progressors versus nonprogressors. Per-patient-per-month costs, which accounted for variable follow-up time, were almost twice as high among progressors versus nonprogressors in patients with mBC, mCRC, and mLC. In each of the three cancer types, delays in progression were associated with lower health care costs. Conclusion Progression of mLC, mBC, and mCRC was associated with higher health care costs over a 12-month period. Delayed cancer progression was associated with substantial cost reductions in patients with each of the three cancer types. Implications for Practice Data on the rates and incremental health care costs of disease progression in patients with solid tumor cancers are lacking. This study estimated the incremental costs of disease progression in patients diagnosed with lung cancer, breast cancer, and colorectal cancer and compared health care costs in patients with and without evidence of disease progression in a real-world population. The data obtained in our study quantify the economic value of delaying or preventing disease progression and may inform payers and physician groups about value-based payment programs." @default.
• W2917999849 created "2019-03-02" @default.
• W2917999849 creator A5006112971 @default.
• W2917999849 creator A5026481882 @default.
• W2917999849 creator A5028025833 @default.
• W2917999849 creator A5032859004 @default.
• W2917999849 creator A5041791973 @default.
• W2917999849 creator A5049461398 @default.
• W2917999849 creator A5051465568 @default.
• W2917999849 creator A5057312624 @default.
• W2917999849 creator A5087419260 @default.
• W2917999849 date "2019-02-22" @default.
• W2917999849 modified "2023-10-05" @default.
• W2917999849 title "Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer" @default.
• W2917999849 cites W1544539327 @default.
• W2917999849 cites W1575708198 @default.
• W2917999849 cites W1979160865 @default.
• W2917999849 cites W2003355055 @default.
• W2917999849 cites W2008716022 @default.
• W2917999849 cites W2041045729 @default.
• W2917999849 cites W2050056063 @default.
• W2917999849 cites W2085079161 @default.
• W2917999849 cites W2094417124 @default.
• W2917999849 cites W2110556979 @default.
• W2917999849 cites W2113411375 @default.
• W2917999849 cites W2113848418 @default.
• W2917999849 cites W2121656227 @default.
• W2917999849 cites W2129803870 @default.
• W2917999849 cites W2139963961 @default.
• W2917999849 cites W2155029562 @default.
• W2917999849 cites W2168662061 @default.
• W2917999849 cites W234152640 @default.
• W2917999849 cites W2401338497 @default.
• W2917999849 cites W28400483 @default.
• W2917999849 doi "https://doi.org/10.1634/theoncologist.2018-0018" @default.
• W2917999849 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6738320" @default.
• W2917999849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30796156" @default.
• W2917999849 hasPublicationYear "2019" @default.
• W2917999849 type Work @default.
• W2917999849 sameAs 2917999849 @default.
• W2917999849 citedByCount "20" @default.
• W2917999849 countsByYear W29179998492020 @default.
• W2917999849 countsByYear W29179998492021 @default.
• W2917999849 countsByYear W29179998492022 @default.
• W2917999849 countsByYear W29179998492023 @default.
• W2917999849 crossrefType "journal-article" @default.
• W2917999849 hasAuthorship W2917999849A5006112971 @default.
• W2917999849 hasAuthorship W2917999849A5026481882 @default.
• W2917999849 hasAuthorship W2917999849A5028025833 @default.
• W2917999849 hasAuthorship W2917999849A5032859004 @default.
• W2917999849 hasAuthorship W2917999849A5041791973 @default.
• W2917999849 hasAuthorship W2917999849A5049461398 @default.
• W2917999849 hasAuthorship W2917999849A5051465568 @default.
• W2917999849 hasAuthorship W2917999849A5057312624 @default.
• W2917999849 hasAuthorship W2917999849A5087419260 @default.
• W2917999849 hasBestOaLocation W29179998491 @default.
• W2917999849 hasConcept C121608353 @default.
• W2917999849 hasConcept C126322002 @default.
• W2917999849 hasConcept C143998085 @default.
• W2917999849 hasConcept C160735492 @default.
• W2917999849 hasConcept C162324750 @default.
• W2917999849 hasConcept C167135981 @default.
• W2917999849 hasConcept C2775930923 @default.
• W2917999849 hasConcept C2776256026 @default.
• W2917999849 hasConcept C2779134260 @default.
• W2917999849 hasConcept C50522688 @default.
• W2917999849 hasConcept C526805850 @default.
• W2917999849 hasConcept C530470458 @default.
• W2917999849 hasConcept C71924100 @default.
• W2917999849 hasConceptScore W2917999849C121608353 @default.
• W2917999849 hasConceptScore W2917999849C126322002 @default.
• W2917999849 hasConceptScore W2917999849C143998085 @default.
• W2917999849 hasConceptScore W2917999849C160735492 @default.
• W2917999849 hasConceptScore W2917999849C162324750 @default.
• W2917999849 hasConceptScore W2917999849C167135981 @default.
• W2917999849 hasConceptScore W2917999849C2775930923 @default.
• W2917999849 hasConceptScore W2917999849C2776256026 @default.
• W2917999849 hasConceptScore W2917999849C2779134260 @default.
• W2917999849 hasConceptScore W2917999849C50522688 @default.
• W2917999849 hasConceptScore W2917999849C526805850 @default.
• W2917999849 hasConceptScore W2917999849C530470458 @default.
• W2917999849 hasConceptScore W2917999849C71924100 @default.
• W2917999849 hasIssue "9" @default.
• W2917999849 hasLocation W29179998491 @default.
• W2917999849 hasLocation W29179998492 @default.
• W2917999849 hasLocation W29179998493 @default.
• W2917999849 hasLocation W29179998494 @default.
• W2917999849 hasOpenAccess W2917999849 @default.
• W2917999849 hasPrimaryLocation W29179998491 @default.
• W2917999849 hasRelatedWork W144521535 @default.
• W2917999849 hasRelatedWork W2037999876 @default.
• W2917999849 hasRelatedWork W2070780645 @default.
• W2917999849 hasRelatedWork W2224319365 @default.
• W2917999849 hasRelatedWork W2372809030 @default.
• W2917999849 hasRelatedWork W2411890706 @default.
• W2917999849 hasRelatedWork W2766672491 @default.
• W2917999849 hasRelatedWork W2979892935 @default.
• W2917999849 hasRelatedWork W3181412252 @default.

• next